Description
| Peptide | CJC no DAC |
|---|---|
| mg. | 5 |
| Identity | CJC no DAC |
In Testing
Researchers study CJC-1295 No DAC in the context of:
• growth hormone–releasing hormone signaling pathways
• short-acting stimulation of endogenous growth hormone release aligned with natural pulsatile patterns
• transient growth hormone signaling without extended peptide half-life (no DAC modification)
• hypothalamic-pituitary axis regulation and feedback mechanisms
• insulin-like growth factor-1 mediated signaling cascades
• temporal dynamics of growth hormone pulse frequency and amplitude
• metabolic regulation and nutrient partitioning pathways
• lipid metabolism and fat utilization signaling
• muscle tissue maintenance and recovery-related signaling
• bone density and connective tissue signaling pathways
• sleep-associated growth hormone release patterns and circadian rhythm alignment
• neuroendocrine coordination between growth hormone signaling and metabolic processes
• comparative studies of short-acting vs. long-acting GHRH analogs
